NCT02183363View on ClinicalTrials.gov

Bioavailability of BI 1356 After Single Oral Administration Given as Different Tablet Formulation in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

May 31, 2007

Conditions
Healthy
Interventions
DRUG

BI 1356 - Tablet TFII

DRUG

BI 1356 - Tablet iFF

DRUG

BI 1356 - Tablet TFIIb

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY